Sponsored by the Annenberg Center for Health Sciences at Eisenhower

1
Sponsored by the Annenberg Center for Health
Sciences at Eisenhower
Supported by an independent educational grant
from Daiichi Sankyo, Inc. and Eli Lilly and
Company
This event is not part of the official Scientific
Sessions 2006 as planned by the AHA Committee on
Scientific Sessions Program
2
Introduction and Controversiesin Antiplatelet
Therapy
Eugene Braunwald, MD, MACC Harvard Medical
School Boston, MA
3
(No Transcript)
4
(No Transcript)
5
(No Transcript)
6
Downloaded from Heart Disease (on 16 October
2006 0527 PM)
7
Innovations in Optimizing Antiplatelet Therapy
Program Goals

• Discuss strategies to improve
• Adoption of ACC/AHA guidelines
• Pharmacologic agents efficacy/safety
• Platelet resistance issues
• Assess controversies in management
• Review future treatment options
• Present/discuss ACS case studies